Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram

P. Svenningsson; L. Berg; D. Matthews; D. F. Ionescu; E. M. Richards; M. J. Niciu; A. Malinger; M. Toups; H. Manji; M. H. Trivedi; C. A. Zarate; P. Greengard

doi:10.1038/mp.2014.13

Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram

P. Svenningsson, L. Berg, D. Matthews, D. F. Ionescu, E. M. Richards, M. J. Niciu, A. Malinger, M. Toups, H. Manji, M. H. Trivedi, C. A. Zarate, P. Greengard

Research output: Contribution to journal › Letter › peer-review

24 Scopus citations

Original language	English (US)
Pages (from-to)	962-964
Number of pages	3
Journal	Molecular psychiatry
Volume	19
Issue number	9
DOIs	https://doi.org/10.1038/mp.2014.13
State	Published - Sep 11 2014
Externally published	Yes

ASJC Scopus subject areas

Molecular Biology
Psychiatry and Mental health
Cellular and Molecular Neuroscience

Access to Document

10.1038/mp.2014.13

Cite this

Svenningsson, P., Berg, L., Matthews, D., Ionescu, D. F., Richards, E. M., Niciu, M. J., Malinger, A., Toups, M., Manji, H., Trivedi, M. H., Zarate, C. A., & Greengard, P. (2014). Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram. Molecular psychiatry, 19(9), 962-964. https://doi.org/10.1038/mp.2014.13

Svenningsson, P, Berg, L, Matthews, D, Ionescu, DF, Richards, EM, Niciu, MJ, Malinger, A, Toups, M, Manji, H, Trivedi, MH, Zarate, CA & Greengard, P 2014, 'Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram', Molecular psychiatry, vol. 19, no. 9, pp. 962-964. https://doi.org/10.1038/mp.2014.13

@article{da437605086046d0a60bddde2294d8b1,

title = "Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram",

author = "P. Svenningsson and L. Berg and D. Matthews and Ionescu, {D. F.} and Richards, {E. M.} and Niciu, {M. J.} and A. Malinger and M. Toups and H. Manji and Trivedi, {M. H.} and Zarate, {C. A.} and P. Greengard",

note = "Funding Information: This study was supported in part by the Intramural Research Program of the National Institute of Mental Health (DM, DFI, ER, MN, AM, HM, CAZ), National Institutes of Health (IRP-NIMH-NIH), by NIMH MH090963 (PG), JPB Foundation (PG), Fisher Center for Alzheimer{\textquoteright}s research Foundation (PG, PS) and by the Swedish Medical Research Council (PS). Funding Information: Netherland Twin Register and Netherlands Study of Depression and Anxiety (NESDA): Funding was obtained from the Netherlands Organization for Scientific Research (NWO) and MagW/ZonMW grants Middelgroot-911-09-032, Spinozapremie 56-464-14192, Geestkracht program of the Netherlands Organization for Health Research and Development (ZonMW 10-000-1002), Center for Medical Systems Biology (CSMB, NWO Genomics), Genetic influences on stability and change in psychopathology from childhood to young adulthood (ZonMW 912-10-020), NBIC/BioAssist/RK(2008.024), Biobanking and Biomolecular Resources Research Infrastructure (BBMRI–NL, 184.021.007), VU University{\textquoteright}s Institute for Health and Care Research (EMGO+) and Neuroscience Campus Amsterdam (NCA); the European Science Council (ERC Advanced, 230374). Part of the genotyping and analyses were funded by the Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health, Rutgers University Cell and DNA Repository (NIMH U24 MH068457-06), the Avera Institute, Sioux Falls, South Dakota (USA) and the National Institutes of Health (NIH R01 HD042157-01A1, MH081802, Grand Opportunity grants 1RC2 MH089951 and 1RC2 MH089995).",

year = "2014",

month = sep,

day = "11",

doi = "10.1038/mp.2014.13",

language = "English (US)",

volume = "19",

pages = "962--964",

journal = "Molecular Psychiatry",

issn = "1359-4184",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram

AU - Svenningsson, P.

AU - Berg, L.

AU - Matthews, D.

AU - Ionescu, D. F.

AU - Richards, E. M.

AU - Niciu, M. J.

AU - Malinger, A.

AU - Toups, M.

AU - Manji, H.

AU - Trivedi, M. H.

AU - Zarate, C. A.

AU - Greengard, P.

N1 - Funding Information: This study was supported in part by the Intramural Research Program of the National Institute of Mental Health (DM, DFI, ER, MN, AM, HM, CAZ), National Institutes of Health (IRP-NIMH-NIH), by NIMH MH090963 (PG), JPB Foundation (PG), Fisher Center for Alzheimer’s research Foundation (PG, PS) and by the Swedish Medical Research Council (PS). Funding Information: Netherland Twin Register and Netherlands Study of Depression and Anxiety (NESDA): Funding was obtained from the Netherlands Organization for Scientific Research (NWO) and MagW/ZonMW grants Middelgroot-911-09-032, Spinozapremie 56-464-14192, Geestkracht program of the Netherlands Organization for Health Research and Development (ZonMW 10-000-1002), Center for Medical Systems Biology (CSMB, NWO Genomics), Genetic influences on stability and change in psychopathology from childhood to young adulthood (ZonMW 912-10-020), NBIC/BioAssist/RK(2008.024), Biobanking and Biomolecular Resources Research Infrastructure (BBMRI–NL, 184.021.007), VU University’s Institute for Health and Care Research (EMGO+) and Neuroscience Campus Amsterdam (NCA); the European Science Council (ERC Advanced, 230374). Part of the genotyping and analyses were funded by the Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health, Rutgers University Cell and DNA Repository (NIMH U24 MH068457-06), the Avera Institute, Sioux Falls, South Dakota (USA) and the National Institutes of Health (NIH R01 HD042157-01A1, MH081802, Grand Opportunity grants 1RC2 MH089951 and 1RC2 MH089995).

PY - 2014/9/11

Y1 - 2014/9/11

UR - http://www.scopus.com/inward/record.url?scp=84927177561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927177561&partnerID=8YFLogxK

U2 - 10.1038/mp.2014.13

DO - 10.1038/mp.2014.13

M3 - Letter

C2 - 24614495

AN - SCOPUS:84927177561

SN - 1359-4184

VL - 19

SP - 962

EP - 964

JO - Molecular Psychiatry

JF - Molecular Psychiatry

IS - 9

ER -

Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this